🔗 Permalink

Assignee profile:

ARON H. BLAESI

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-12-11

Patent Grants:

Last grant date:

2024-08-13

Top Inventors for applications by ARON H. BLAESI

These are the the leading inventors for applications assigned to ARON H. BLAESI:

ARON H. BLAESI 21 Cambridge, MA United States
NANNAJI SAKA 21 Cambridge, MA United States
Aron H. Blaesi 7 , United States

Recent patent applications by ARON H. BLAESI

ARON H. BLAESI based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-11

US20250375383A1

Human necessities

Structured solid dosage form

#2 | 2025-03-27

US20250099375A9

Human necessities

Expandable multi-excipient dosage form

#3 | 2025-03-06

US20250078159A1

Physics

Apparatus for 3D-micro-patterning

#4 | 2025-02-27

US20250064727A1

Human necessities

Gastroretentive fibrous dosage form for prolonged drug delivery

#5 | 2024-11-14

US20240374531A1

Human necessities

Apparatus for the manufacture of solid dosage forms

#6 | 2024-06-20

US20240197644A1

Human necessities

Expandable structured dosage form for prolonged drug delivery

#7 | 2023-11-30

US20230381115A1

Human necessities

Close-packed fibrous dosage form

#8 | 2023-07-27 ✅ Patent 12,059,503 granted on 2024-08-13

US20230233478A1

Human necessities

Method for the manufacture of solid dosage forms

#9 | 2023-07-27

US20230233458A1

Human necessities

Gastroretentive structured dosage form

#10 | 2022-09-29

US20220304924A1

Human necessities

Expandable multi-excipient dosage form

#11 | 2021-10-28

US20210330593A1

Human necessities

Structured solid dosage form

#12 | 2021-09-23 ✅ Patent 12,201,731 granted on 2025-01-21

US20210290559A1

Human necessities

Method for 3D-micro-patterning

#13 | 2021-07-15 ✅ Patent 12,251,465 granted on 2025-03-18

US20210212943A1

Human necessities

Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof

#14 | 2021-06-10 ✅ Patent 11,285,116 granted on 2022-03-29

US20210169821A1

Human necessities

Method for the manufacture of fibrous dosage forms

#15 | 2020-10-22 ✅ Patent 11,478,427 granted on 2022-10-25

US20200330388A1

Human necessities

Dosage form comprising structural framework of two-dimensional elements

#16 | 2020-08-27 ✅ Patent 11,865,216 granted on 2024-01-09

US20200268680A1

Human necessities

Expandable structured dosage form for immediate drug delivery

#17 | 2019-11-14

US20190344485A1

Performing operations; transporting

Method and apparatus for the manufacture of cellular solids

#18 | 2018-10-25

US20180303943A1

Human necessities

Dosage form comprising two-dimensional structural elements

#19 | 2018-09-27 ✅ Patent 10,751,292 granted on 2020-08-25

US20180271797A1

Human necessities

Method and apparatus for the manufacture of fibrous dosage forms

#20 | 2018-02-22 ✅ Patent 11,129,798 granted on 2021-09-28

US20180049993A1

Human necessities

Fibrous dosage form

#21 | 2016-06-30

US20160184230A1

Human necessities

MELT-PROCESSED POLYMERIC CELLULAR DOSAGE FORM

Also check out Aron H. Blaesi's (Cambridge, United States) applicant profile with 14 patent applications submitted.

AssigneeID:

109991 ⎘